Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
1 Many fertility clinics will ask about GLP-1 use during initial consultations
Use it to understand the routine, not to make dosing decisions
The chart below shows the Retatrutide weight loss results based on the dose and duration: The Retatrutide clinical trials are still underway with a planned Phase IV beyond the current Phase III
CagriSema showed 22.7% at 68 weeks, but Novo Nordisk is running a direct head-to-head trial (NCT06131437) that will settle the comparison in a way indirect data cannot
US$ 21.24
US$ 22.83
US$ 24.62
US$ 28.34
US$ 26.20
US$ 27.00
US$ 24.17
US$ 27.14
